Top Markets
#1 Nesa Nesa +802.33%
#2 Cortex Cortex +68.77%
#3 Kinesis Silver Kinesis Silver +55.82%
#4 Merlin's Seal BTC Merlin's Seal BTC +45.67%
#5 QuantixAI QuantixAI +24.00%
#6 EXOD EXOD +22.78%
#7 Cash Cat Cash Cat +21.46%
#8 OpenEden OpenEden +17.35%
#9 Instadapp Instadapp +16.92%
#10 Alchemist AI Alchemist AI +14.61%
Coin of the day
Nesa Nesa
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen Salubris Pharmaceuticals Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

002294
Rang in aandelen #3532
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Aandeelprijs
$4.64
Marktkapitalisatie
$5.17B
Verandering (1 dag)
0.34%
Verandering (1 jaar)
-37.46%
Land
CN
Handel Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)

Categorie

Healthcare
Aandelsplitsingen voor Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Het aandeel Shenzhen Salubris Pharmaceuticals Co., Ltd. (symbool: 002294) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 26, 2026.
Eén aandeel 002294 dat vóór Aug 26, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 002294.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 3 x4
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 3 x20
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 0 -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 6 x20
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 0 -
CH